|
|
 Previous Article | Table of Contents | Next Article 
Blood, Vol. 92 No. 11 (December 1), 1998:
pp. 4248-4255
Role of Spontaneous and Interleukin-2-Induced Natural Killer Cell
Activity in the Cytotoxicity and Rejection of Fas+
and Fas Tumor Cells
Mike Bradley,
Ahmet Zeytun,
Asimah Rafi-Janajreh,
Prakash S. Nagarkatti, and
Mitzi Nagarkatti
From the Department of Biology and the Department of Biomedical
Sciences & Pathobiology, Virginia-Maryland College of Veterinary
Medicine, Virginia Tech, Blacksburg, VA.
In the current study, we investigated whether the naive, poly I:C or
interleukin-2 (IL-2)-induced natural killer (NK)/lymphokine-activated killer (LAK) cells use perforin and/or Fas ligand
(FasL) to mediated cytotoxicity. We correlated these findings with the
ability of mice to reject syngeneic Fas+ and
Fas tumor cells either spontaneously or after IL-2
treatment. The spontaneous NK-cell-mediated cytotoxicity was primarily
perforin based, whereas the poly I:C and IL-2-induced NK/LAK activity
was both FasL and perforin dependent. L1210 Fas+ tumor
targets were more sensitive than L1210 Fas targets to
poly I:C and IL-2-induced cytotoxicity in wild-type, gld/gld,
and perforin knockout mice. When L1210 Fas+ and
Fas- tumor cells were injected subcutaneously (sc) or
intraperitoneally into syngeneic mice, Fas tumor cells
caused mortality earlier than Fas+ tumor cells. Also,
approximately 20% of the mice injected sc with L1210
Fas+ tumor cells survived the challenge(>60 days),
whereas all mice injected similarly with L1210 Fas tumor
cells died. When immunotherapy using IL-2 (10,000 U, three times/d for
a week, followed by once/d for an additional week) was attempted in
mice injected sc with tumor cells, IL-2 treatment was very effective
against mice bearing L1210 Fas+ (40% survival) but not
L1210 Fas (0% survival) tumors. These data correlated
with the finding that the LAK cells from IL-2-injected mice caused
increased cytotoxicity against L1210 Fas+ when compared
with L1210 Fas targets. Also, L1210 Fas+
tumor-bearing mice showed increased tumor-specific cytotoxic T
lymphocyte (CTL) activity when compared with those bearing L1210 Fas tumor cells. Together our studies show for the first
time that expression of Fas on tumor targets makes them more
immunogenic as well as susceptible to CTL- and IL-2-induced LAK
activity. The Fas+ tumor cells are also more responsive
to immunotherapy with IL-2.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Vermijlen, D. Luo, C. J Froelich, J. P. Medema, J. A. Kummer, E. Willems, F. Braet, and E. Wisse
Hepatic natural killer cells exclusively kill splenic/blood natural killer-resistant tumor cells by the perforin/granzyme pathway
J. Leukoc. Biol.,
October 1, 2002;
72(4):
668 - 676.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Wilson and A. J. Morgan
Primary Immune Responses by Cord Blood CD4+ T Cells and NK Cells Inhibit Epstein-Barr Virus B-Cell Transformation In Vitro
J. Virol.,
April 16, 2002;
76(10):
5071 - 5081.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
X. F. Li, D. S. Charnock-Jones, E. Zhang, S. Hiby, S. Malik, K. Day, D. Licence, J. M. Bowen, L. Gardner, A. King, et al.
Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells
J. Clin. Endocrinol. Metab.,
April 1, 2001;
86(4):
1823 - 1834.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. P. Bruno, D. Lautier, A. d. T. d'Orgeix, G. Laurent, and A. Quillet-Mary
Acute myeloblastic leukemic cells acquire cellular cytotoxicity under genotoxic stress: implication of granzyme B and perforin
Blood,
September 1, 2000;
96(5):
1914 - 1920.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Berthou, J.-F. Bourge, Y. Zhang, A. Soulie, D. Geromin, Y. Denizot, F. Sigaux, and M. Sasportes
Interferon-gamma -induced membrane PAF-receptor expression confers tumor cell susceptibility to NK perforin-dependent lysis
Blood,
April 1, 2000;
95(7):
2329 - 2336.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Rosen, J.-H. Li, S. Keidar, I. Markon, R. Orda, and G. Berke
Tumor Immunity in Perforin-Deficient Mice: A Role for CD95 (Fas/APO-1)
J. Immunol.,
March 15, 2000;
164(6):
3229 - 3235.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Kayagaki, N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, and H. Yagita
Expression and Function of TNF-Related Apoptosis-Inducing Ligand on Murine Activated NK Cells
J. Immunol.,
August 15, 1999;
163(4):
1906 - 1913.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Q. Rafi-Janajreh, D. Chen, R. Schmits, T. W. Mak, R. L. Grayson, D. P. Sponenberg, M. Nagarkatti, and P. S. Nagarkatti
Evidence for the Involvement of CD44 in Endothelial Cell Injury and Induction of Vascular Leak Syndrome by IL-2
J. Immunol.,
August 1, 1999;
163(3):
1619 - 1627.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
